PEP503 (NBTXR3), a radioenhancer, in combination with concurrent chemoradiation (CCRT) in locally advanced or recurrent head and neck squamous cell carcinoma (HNSCC): Dose-finding of a phase 1b/2 trial.

被引：0
|
作者：
Wang, Cheng-Hsu
Chao, K. S. Clifford
Chen, Ping-Tsung
Yeh, Kun-Yun
Chen, Yen-Chao
Chen, Yao-Liang
Yang, Shih-Wei
Wu, Tsung-Han
Chang, Pei-Hung
Young, Chi-Kuang
Tsan, Din-Li
Tsai, Ming-Hsui
Hsieh, Ching-Yun
Chen, Wen-Cheng
Tsai, Yuan-Hsiung
Hsu, Cheng-Ming
Chang, John W. C.
Yu, Wei-Che
Shen, Bor-Nian
机构：
[1] Chang Gung Mem Hosp, Keelung, Taiwan
[2] Chang Gung Univ, Coll Med, Keelung, Taiwan
[3] China Med Univ Hosp, Canc Ctr, Taichung, Taiwan
[4] Chiayi Chang Gung Memoal Hosp, Putz, Chiayi, Taiwan
[5] Chang Gung Mem Hosp, Keelung, Taiwan
[6] Keelung Chang Gung Mem Hosp, Keelung, Taiwan
[7] Chang Gung Univ, Chang Gung Mem Hosp, Taoyuan City, Taiwan
[8] Chang Gung Mem Hosp, Dept Internal Med, Keelung, Taiwan
[9] China Med Univ Hosp, Taichung, Taiwan
[10] Chiayi Chang Gung Memor Hosp, Chiayi, Taiwan
[11] Chang Gung Med & Nursing Village, Kweshan Hsiang, Taiwan
[12] PharmaEngine Inc, Taipei, Taiwan
[13] PharmaEngine, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18041
引用
收藏
页码：E18041 / E18041
页数：1
相关论文
共 42 条
  • [1] A new radio-enhancer, PEP503 (NBTXR3), in combination with concurrent chemoradiation in locally advanced or unresectable rectal cancer: The dose-finding part of a phase I/II trial.
    Wang Jaw-Yuan
    Huang Ching-Wen
    Huang Ming-Yii
    Hu Huang-Ming
    Hsu Wen-Hung
    Shih Hsiang-Yao
    Chen Chiao-Yun
    Chen Chou-Pin
    Chao, Jeffrey Yung-Chuan
    Chiu You-Hisin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [2] A phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma (HNSCC)
    Yang, E. S.
    Deutsch, E.
    Mehmet, A.
    Fayette, J.
    Nabell, L.
    Spencer, S. A.
    Dobelbower, M. C.
    Willey, C. D.
    Bonner, J. A.
    Wang, X.
    Lin, A.
    William, W. N.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1136 - 1136
  • [3] Phase 1b/ 2 study of a radio-enhancer, PEP503 (NBTXR3), in combination with concurrent chemo-radiation in locally advanced or unresectable rectal cancer.
    Huang, Ching-Wen
    Wang, Jaw-Yuan
    Chen, Chou-Pin
    Wei, Po-Li
    Hu, Huang-Ming
    Hsu, Wen-Hung
    Shih, Hsiang-Yao
    Huang, Ming-Yii
    Chen, Chiao-Yun
    Kuo, Chao-Hung
    Chen, Chou-Chen
    Chiang, Tzu-Wei
    Chao, Jeffrey Yung-Chuan
    Chiu, You-Hsin
    Tiong, Cheng
    Lin, Pao-Ying
    Lu, Long-Sheng
    Kung, Ching-Huei
    Yu, Wei-Che
    Wu, Yu-Shan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma
    Yang, Eddy S.
    Deutsch, Eric
    Mehmet, Altan
    Fayette, Jerome
    Tao, Yungan
    Nabell, Lisle
    Spencer, Sharon A.
    Wang, Xuejing A.
    Spoljoric, Elizabeth A.
    Zhang, Wei
    Hynes, Scott M.
    Decker, Rodney L.
    Lin, Aimee K. Bence
    William, William N., Jr.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 157 : 203 - 209
  • [5] A phase I dose-finding study of metformin in combination with concurrent cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma
    Gulati, Shuchi
    Yaniv, Benyamin
    Palackdharry, Sarah
    Takiar, Vinita
    Mierzwa, Michelle Lynn
    Riaz, Muhammad Kashif
    Morris, John Charles
    Xie, Changchun
    Gutkind, J. Silvio
    Desai, Pankaj B.
    Sadraei, Nooshin Hashemi
    Wise-Draper, Trisha Michel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer
    Gulati, Shuchi
    Desai, Janki
    Palackdharry, Sarah M.
    Morris, John C.
    Zhu, Zheng
    Jandarov, Roman
    Riaz, Muhammad K.
    Takiar, Vinita
    Mierzwa, Michelle
    Gutkind, J. Silvio
    Molinolo, Alfredo
    Desai, Pankaj B.
    Sadraei, Nooshin Hashemi
    Wise-Draper, Trisha M.
    [J]. CANCER, 2020, 126 (02) : 354 - 362
  • [7] Elderly patients with locally advanced head and neck squamous cell carcinoma treated with NBTXR3 nanoparticles activated by radiotherapy: A phase I trial
    Le Tourneau, C.
    Calugaru, V.
    Moreno, V.
    Mirabel, X.
    Dodger, B.
    Calvo, E.
    Jouffroy, T.
    Rodriguez, J.
    Chilles, A.
    Yemi, M.
    Hoffmann, C.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [8] Phase 2 Trial of AT-101 in Combination With Docetaxel for Recurrent, Locally Advanced, or Metastatic Head-and-Neck Squamous Cell Carcinoma (HNSCC) Management of Recurrent Head-and-Neck Squamous Cell Carcinoma
    Sacco, A.
    Nor, J.
    Belile, E.
    Sukari, A.
    Chepeha, D.
    Bradford, C.
    Eisbruch, A.
    Wolf, G.
    Urba, S.
    Worden, F.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 507 - 507
  • [9] Phase 1b trial of LY2606368 in combination with chemoradiation in patients with locally advanced head and neck squamous cell cancer
    Yang, E.
    William, W.
    Fayette, J.
    Zhang, W.
    Fink, A.
    Lin, A. B.
    Deutsch, E.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [10] A phase III randomized trial of two cisplatin-based concurrent chemoradiation (CCRT) regimens for locally advanced head and neck squamous cell carcinoma (LAHNSCC)
    Rodriguez, Cristina P.
    Adelstein, David J.
    Rybicki, Lisa A.
    Savvides, Panayiotis
    Saxton, Jerrold P.
    Koyfman, Shlomo A.
    Greskovich, John
    Yao, Min
    Scharpf, Joseph
    Lavertu, Pierre
    Wood, Benjamin J.
    Burkey, Brian
    Lorenz, Robert
    Rezaee, Rod
    Zender, Chad
    Ives, Denise I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345